Table 2.
CSP latency and duration measured from upper and lower extremities of patients and controls groups.
| CSP (ms) | Patient group (n = 25) mean ± SD |
Control group (n = 23) mean ± SD |
P value |
|---|---|---|---|
| Upper extremity | |||
| Latency | 69.1 ± 15.4 | 58.6 ± 16.2 | 0.034* |
| Duration | 56.6 ± 20.0 | 67.9 ± 19.9 | 0.039* |
| Lower extremity | |||
| Latency | 89.9 ± 32.6 | 88.3 ± 12.3 | 0.103 |
| Duration | 35.7 ± 20.6 | 55.6 ± 15.6 | 0.001* |
SD: standard deviation; CSP: cutaneous silent period, *P < 0.05.